Modification of New York Ruling Letter K83806; classification of monoclonal antibody medicaments
Reasoning
Modification of New York Ruling Letter K83806; classification of monoclonal antibody medicaments
Cite this ruling
CBP Ruling H110421 (30021001): Modification of New York Ruling Letter K83806; classification of monoclonal antibody medicaments
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300210
The tariff classification of monoclonal antibodies in bulk and measured dosage forms, from England, Ireland, and Germany
The tariff classification of Rubella IgG 34430, TBIL reagent 442745, IgG reagent 446400, Reagent kit IM 1579 RIA Free T3 and GenomeLab™ GeXP Human MetastasisPlex Kit A32712, from France
The tariff classification of Rabbit Antibody Serum and Chicken Antibody IgY from China
The tariff classification of a solid phase enzyme-linked immunosorbent assay (ELISA) for the estimation of rat or mouse Glutathione S-Transferases in biological fluids, in kit form, from Ireland
The tariff classification of an Immunohistochemistry Staining Detection Kit